Anti-Inflammatory drug colchicine tested to boost insulin sensitivity in type 1 diabetes

NCT ID NCT07247734

First seen Jan 09, 2026 · Last updated May 04, 2026 · Updated 20 times

Summary

This study tests whether colchicine, an anti-inflammatory drug, can improve how well the body responds to insulin in people with type 1 diabetes who have low-grade inflammation. About 26 adults will receive either colchicine or a placebo for a period, and their insulin sensitivity will be measured using a special glucose clamp test. The goal is to see if adding colchicine to standard care helps control blood sugar better.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup, Capital Region 2900

    RECRUITING

    Gentofte Municipality, 2400, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.